http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-102565-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G73-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L79-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-08
filingDate 1998-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db7a1b72be14fac1b4fb81fbe2eca810
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c71805d946ffbe3acbb664cc362b9f5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cf93d6205cc6ebd813d55c9abece003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ba04a9ef0a2a0f78e9c78208896ce2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad3e44e8c2e29ef5e4958714fa44c5d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_533ec2721f90f0765196beae1fc0ff6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4283c397cdccc63426a55925bcb79145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57e09c703b9c3673169a6573e952f88f
publicationDate 1999-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BG-102565-A
titleOfInvention WASHING POLYMER COMPLEXES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICALS THAT CONTAIN THEM
abstract The compounds are used for diagnosis and therapy. They comprise the following components: a) complexing ligands of the general formula A- {X- [Y- (Z- <W-Kwz) y] x} a, wherein A represents a nitrogen containing baseplate of basic multiplicity? and Y independently of one another are a direct link or a stepped reproduction unit with a reproduction multiplicity x, respectively, y, Z and W are each independently a reproductive unit of reproduction multiplicity z, w, K is a complexing agent residue, and has a value of 2 to 12, x, y, z and w each independently from 1 to 4, provided at least two reproduction units are different, and for the multiplication product the condition 16 is a. x. y. z. w <64 and that at least one stepped reproduction unit X, Y, Z, W is a 1,4,7,10-tetraazacyclododecanoic or 1,4,8,11-tetraazacyclotetradecan reprocessing unit; (b) at least 16 ions of an element of sequence number 20 to 29, 39, 42, 44 or 57-83; c) optionally cations of inorganic and / or organic bases, amino acids or amino acid amides, and d) optionally acylated terminal amino groups.
priorityDate 1995-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578879

Total number of triples: 35.